Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 36884302

Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2023 Aug 8
First author
Whitlock JA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Whitlock JA
      type
      Author
    2. name
      Geoerger B
      type
      Author
    3. name
      Dunkel IJ
      type
      Author
    4. name
      Roughton M
      type
      Author
    5. name
      Choi J
      type
      Author
    6. name
      Osterloh L
      type
      Author
    7. name
      Russo M
      type
      Author
    8. name
      Hargrave D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Whitlock JA
      type
      Author
    2. name
      Geoerger B
      type
      Author
    3. name
      Dunkel IJ
      type
      Author
    4. name
      Roughton M
      type
      Author
    5. name
      Choi J
      type
      Author
    6. name
      Osterloh L
      type
      Author
    7. name
      Russo M
      type
      Author
    8. name
      Hargrave D
      type
      Author
    bibliography ids
    1. nci-bib-351bdf2155b7ea77a3529665
    book metadata
    content sha256
    986481c62b1897a0e53b190ab241b61ecd219007e36c2f5ef7c1f7fbf039de3d
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2022008414
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36884302
    immutable id
    pubmed:36884302@986481c62b1897a0e53b190ab241b61ecd219007e36c2f5ef7c1f7fbf039de3d
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    15
    name
    Blood advances
    nlm unique id
    101698425
    pages
    3806-3815
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36884302
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      4c42ba4ea487d51b25a9737583f12b46a4adc09ca10229c8ee6a451e9f0e9ab5
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2023 Aug 8
      precision
      day
      year
      2023
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36884302/
      title
      Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis.

      Preserved source evidence · Independent clinical review pending · Not medical advice